ONO PHARMACEUTICAL COONO PHARMACEUTICAL COONO PHARMACEUTICAL CO

ONO PHARMACEUTICAL CO

No trades
See on Supercharts
Next report date
Report period
Q4 2023
EPS estimate
5.63MXN
Revenue estimate
‪13.49 B‬MXN
Market capitalization
‪119.37 B‬MXN
‪15.30 B‬MXN
‪60.71 B‬MXN
‪307.16 M‬
Beta (1Y)
0.60

About ONO PHARMACEUTICAL CO

CEO
Gyo Sagara
Headquarters
Osaka
Website
Employees (FY)
‪3.76 K‬
Founded
1947
ISIN
JP3197600004
FIGI
BBG014LSN7W9
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 4528/N is 341.69 MXN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange ONO PHARMACEUTICAL CO stocks are traded under the ticker 4528/N.
ONO PHARMACEUTICAL CO is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
4528/N stock is 0% volatile and has beta coefficient of 0.60. Check out the list of the most volatile stocks — is ONO PHARMACEUTICAL CO there?
4528/N earnings for the last quarter are 10.28 MXN per share, whereas the estimation was 11.28 MXN resulting in a −8.78% surprise. The estimated earnings for the next quarter are 8.79 MXN per share. See more details about ONO PHARMACEUTICAL CO earnings.
ONO PHARMACEUTICAL CO revenue for the last quarter amounts to ‪16.18 B‬ MXN despite the estimated figure of ‪14.87 B‬ MXN. In the next quarter revenue is expected to reach ‪18.17 B‬ MXN.
Yes, you can track ONO PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
4528/N net income for the last quarter is ‪4.34 B‬ MXN, while the quarter before that showed ‪4.98 B‬ MXN of net income which accounts for −12.81% change. Track more ONO PHARMACEUTICAL CO financial stats to get the full picture.
Today ONO PHARMACEUTICAL CO has the market capitalization of ‪115.94 B‬, it has decreased by 4.21% over the last week.
ONO PHARMACEUTICAL CO dividend yield was 2.53% in 2022, and payout ratio reached 30.32%. The year before the numbers were 1.83% and 34.53% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4528/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONO PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
4528/N reached its all-time high on Apr 14, 2023 with the price of 521.32 MXN, and its all-time low was 341.69 MXN and was reached on Oct 6, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 28, 2024, the company has ‪3.76 K‬ employees. See our rating of the largest employees — is ONO PHARMACEUTICAL CO on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ONO PHARMACEUTICAL CO technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ONO PHARMACEUTICAL CO stock shows the sell signal. See more of ONO PHARMACEUTICAL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ONO PHARMACEUTICAL CO future price: according to them, 4528/N price has a max estimate of 335.33 MXN and a min estimate of 197.90 MXN. Read a more detailed ONO PHARMACEUTICAL CO forecast: see what analysts think of ONO PHARMACEUTICAL CO and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ONO PHARMACEUTICAL CO EBITDA is ‪23.74 B‬ MXN, and current EBITDA margin is 37.96%. See more stats in ONO PHARMACEUTICAL CO financial statements.